• Intravesical p21 mRNA-LNPs: Advancing Localized Bladder Canc

  2026-08-06

  This study introduces a non-viral strategy using p21 mRNA-loaded lipid nanoparticles for localized intravesical therapy in bladder cancer, demonstrating significant tumor suppression and restored tumor suppressor function. The findings highlight the translational potential of mRNA delivery systems for targeted, minimally invasive cancer treatment.

• 6-FAM SE: Advanced Fluorescent Labeling for Reliable Molecul

  2026-08-06

  6-FAM SE (6-Carboxyfluorescein N-hydroxysuccinimide ester) offers unmatched stability, brightness, and amine reactivity for gene sequencing and protein labeling workflows. Its superior resistance to hydrolysis enables reproducible results even in demanding applications, bridging the gap between high-throughput molecular assays and innovative nanoparticle systems.

• Alisol A Regulates Cholesterol and Mitophagy in Vascular Cog

  2026-08-05

  This study reveals that Alisol A restores cognitive function in a vascular cognitive impairment (VCI) mouse model by activating the AMPK/NAMPT/SIRT1 axis, rebalancing cholesterol metabolism, and enhancing mitophagy. The mechanistic insights highlight NAMPT as a crucial target, presenting new avenues for addressing atherosclerosis-related cognitive decline.

• VE-821 ATR Kinase Inhibitor: Applied DDR Research Workflows

  2026-08-05

  VE-821 is a potent ATR kinase inhibitor that transforms DNA damage response research through its high selectivity and robust radiosensitization. This article provides expert-driven protocol strategies, advanced applications, and troubleshooting tips that help maximize the compound’s impact in DNA repair, epigenetic, and combination therapy studies.

• Wnt and BMP Pathways Shape Neuroectoderm in Hemichordate Dev

  2026-08-04

  This study systematically maps the spatial and functional roles of Wnt and BMP signaling in anterior neuroectoderm (ANE) patterning during gastrulation of the indirect-developing hemichordate Ptychodera flava. Its findings clarify evolutionary conservation and divergence of axis-patterning mechanisms in deuterostomes, with direct relevance for developmental biology and Wnt pathway modulation workflows.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Te

  2026-08-04

  DiI (DiIC18(3)) provides robust, high-contrast labeling of plasma membranes in both live and fixed cells, supporting applications such as neuronal tracing and cell migration assays. It is not suitable for aqueous-only protocols or for labeling intracellular organelles. Proper solvent use and workflow adherence are critical to maintain specificity and fluorescence intensity.

• D-N-Acetylgalactosamine: Technical Guidance for Glycoprotein

  2026-08-03

  D-N-Acetylgalactosamine is a high-purity, water-soluble metabolite essential for biochemical and neurological research, particularly in the structural analysis of brain glycoproteins and glycosylation pathways. It is not suitable for workflows requiring ethanol solubility or long-term storage of prepared solutions, and strict adherence to handling protocols is necessary to maintain reproducibility.

• Irisin Preserves Mitochondrial Function in Renal I/R Injury

  2026-08-03

  The referenced study demonstrates that irisin, a myokine released during exercise, preserves mitochondrial integrity and function in tubular epithelial cells following ischemia–reperfusion-induced acute kidney injury (AKI). By dissecting the molecular mechanisms and using a rigorous in vivo and ex vivo approach, the authors reveal irisin’s capacity to modulate mitochondrial autophagy pathways, providing new insight into AKI pathophysiology and potential intervention strategies.

• SGI-1027 and Everolimus Synergize via Lysosomal Membrane Per

  2026-08-02

  The referenced study uncovers how SGI-1027, a DNMT1 inhibitor, enhances the antitumor efficacy of everolimus in renal cell carcinoma by triggering lysosomal membrane permeability, leading to apoptosis and GSDME-dependent pyroptosis. This combinatorial approach addresses everolimus resistance and highlights the importance of lysosomal dynamics in advanced RCC therapy.

• TRPV1 Activation Drives Allokinesis in Chronic Dermatitis Mo

  2026-08-01

  A recent study reveals that 20-HETE activates TRPV1 channels on MrgprA3+ neurons, driving abnormal itch (allokinesis) in chronic dermatitis. This mechanistic insight highlights potential therapeutic targets for chronic itch and supports the use of capsaicin analogs for precise TRPV1 modulation in research.

• N1-Methylpseudouridine in mRNA Vaccines: Fidelity and Implic

  2026-07-31

  Kim et al. (2022) provide robust evidence that N1-methylpseudouridine, a key nucleotide modification in COVID-19 mRNA vaccines, preserves translational fidelity and does not compromise protein coding accuracy. Their findings reassure the safety of pseudo-modified uridine triphosphate analogues for advanced mRNA therapeutics, informing best practices for mRNA vaccine development and gene therapy design.

• Sunitinib and Ferroptosis: Next-Generation Insights in RCC R

  2026-07-31

  Discover how Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor, leverages ferroptosis pathways to overcome resistance in renal cell carcinoma studies. This article uniquely explores cutting-edge findings for advancing cancer research.

• Translating Apoptosis Detection: Mechanistic Insights and St

  2026-07-30

  Explore how mechanistic understanding of apoptosis—integrating oxidative stress, DNA fragmentation, and advanced detection methods—guides translational research. This thought-leadership article weaves together the biological rationale, protocol strategies, and strategic imperatives for researchers, highlighting the APExBIO TUNEL Apoptosis Detection Kit (DAB) as a pivotal tool for robust, reproducible DNA fragmentation detection across tissue and cell models.

• Sodium Nitroprusside: Advancing Sex-Difference Vascular Rese

  2026-07-30

  Explore how sodium nitroprusside, a potent nitric oxide donor, is transforming the study of sex differences in hypertension and vascular reactivity. This article delivers mechanistic insights, protocol guidance, and strategic perspectives to empower translational researchers designing preclinical cardiovascular studies.

• Carboplatin: Platinum-Based DNA Synthesis Inhibitor in Cance

  2026-07-29

  Carboplatin is a platinum-based DNA synthesis inhibitor with robust, quantifiable efficacy in preclinical oncology models. Its cytotoxic activity against ovarian and lung cancer cell lines is well-documented, and its mechanistic action is leveraged for both in vitro and in vivo cancer research. This article clarifies evidence, optimal use, and common misconceptions to help researchers select and apply Carboplatin with confidence.

8642 records 9/577 page Previous Next First page 上5页 678910 下5页 Last page